These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19558076)

  • 41. Preventing weight gain: one-year results of a randomized lifestyle intervention.
    ter Bogt NC; Bemelmans WJ; Beltman FW; Broer J; Smit AJ; van der Meer K
    Am J Prev Med; 2009 Oct; 37(4):270-7. PubMed ID: 19765497
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Utilizing trauma nurse practitioners to decrease length of stay.
    Jarrett LA; Emmett M
    J Trauma Nurs; 2009; 16(2):68-72. PubMed ID: 19543014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical results and cost due to improved antibiotics policies].
    Patka P; Boxma H
    Ned Tijdschr Geneeskd; 2000 Feb; 144(7):348. PubMed ID: 10707751
    [No Abstract]   [Full Text] [Related]  

  • 45. A nurse led model of chronic disease care - an interim report.
    Eley DS; Del Mar CB; Patterson E; Synnott RL; Baker PG; Hegney D
    Aust Fam Physician; 2008 Dec; 37(12):1030-2. PubMed ID: 19142279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic use: is appropriateness expensive?
    von Gunten V; Reymond JP; Boubaker K; Gerstel E; Eckert P; Lüthi JC; Troillet N
    J Hosp Infect; 2009 Feb; 71(2):108-11. PubMed ID: 19062133
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Economic impact of pharmacist's interventions: illustration in a rheumatology ward].
    Coursier S; Bontemps H; Brantus JF; Allenet B
    J Pharm Belg; 2008 Dec; 63(4):103-9. PubMed ID: 19320133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Can a chronic disease management pulmonary rehabilitation program for COPD reduce acute rural hospital utilization?
    Rasekaba TM; Williams E; Hsu-Hage B
    Chron Respir Dis; 2009; 6(3):157-63. PubMed ID: 19643830
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Predicting medication costs and usage: expenditures in a juvenile detention facility.
    Tennyson DH
    J Correct Health Care; 2009 Apr; 15(2):98-104; quiz 159. PubMed ID: 19477814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.
    Sharifi E; Porco TC; Naseri A
    Ophthalmology; 2009 Oct; 116(10):1887-96.e1. PubMed ID: 19560825
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of staff education on the practice of 'specialling' by care assistants in an acute care setting.
    Dick A; La Grow S; Boddy J
    Nurs Prax N Z; 2009 Mar; 25(1):17-26. PubMed ID: 19558051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What price commitment: what benefit? The cost of a saved life in a developing level I trauma center.
    Rotondo MF; Bard MR; Sagraves SG; Toschlog EA; Schenarts PJ; Goettler CE; Newell MA; Robertson MJ
    J Trauma; 2009 Nov; 67(5):915-23. PubMed ID: 19901648
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Future pharmacoeconomic criteria for the treatment of infections.
    Milkovich G
    Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S12-4. PubMed ID: 19560668
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prescribing pattern of antibiotics in paediatric hospital of Kathmandu valley.
    Palikhe N
    Kathmandu Univ Med J (KUMJ); 2004; 2(1):6-12. PubMed ID: 19780281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of a renal drug dosing service on dose adjustment in hospitalized patients with chronic kidney disease.
    Hassan Y; Al-Ramahi RJ; Aziz NA; Ghazali R
    Ann Pharmacother; 2009 Oct; 43(10):1598-605. PubMed ID: 19776297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis.
    Duh MS; Dial E; Choueiri TK; Fournier AA; Antras L; Rodermund D; Neary MP; Oh WK
    Curr Med Res Opin; 2009 Aug; 25(8):2081-90. PubMed ID: 19586325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Economic impact of a health care program on antibiotics].
    Susano R; Massalana A; Miranda ML
    Acta Med Port; 1998 Apr; 11(4):323-30. PubMed ID: 9644843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrent lumbar disc herniation after single-level lumbar discectomy: incidence and health care cost analysis.
    Ambrossi GL; McGirt MJ; Sciubba DM; Witham TF; Wolinsky JP; Gokaslan ZL; Long DM
    Neurosurgery; 2009 Sep; 65(3):574-8; discussion 578. PubMed ID: 19687703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.